Summary. Most polypeptides originally assigned to a specific organ and a specific effect seem to occur in many different parts of the body, in neurons as well as in endocrine cells. Thus gastrin and insulin, or very similar peptides can be demonstrated in extracts of the vagal nerves and of peripheral somatic nerves. Electrical stimulation of the sciatic nerve of a perfused cat leg causes appearance of gastrin and insulin like immunoreactivity in the perfusates. This gastrin and insulin like immunoreactivity might originate from nervous depots. If so it might be assumed that insulin and other peptides are released in response to activation of autonomic or somatic nerves and that they might exert local metabolic effects in response to the acute needs of energy in eg. striated or smooth muscles.
The present article describes the presence of peptides in the peripheral nervous system with special references to the vagus nerve of the cat. The peripheral nervous system consists of the autonomic nervous system, including the parasympathetic and the sympathetic nerves, and the peripheral somatic nerves. All of these contain sensory as well as motor neurons. Until recently acetylcholine was considered to be the main transmitter substance in the preganglionic sympathetic and parasympathetic motor fibres, in the postganglionic parasympathetic motor fibres and also in the peripheral somatic motor nerves. Noradrenaline was supposed to be the transmitter of the sympathetic postganglionic motor fibres. Very little was known about the transmitter or transmitters of the sensory neurons in the peripheral nervous system.
The vagal nerve is the main regulator of gastrointestinal function. According to pharmacological terminology, vagally induced effects are mediated via cholinergic receptors of the muscarinic type and can therefore be blocked by atropine. However, exceptions to this rule were described before the era of peptides. For example, Martinsson [5] showed that the gastric relaxation which could be induced by electrical vagal stimulation using impulses of long duration (-2 msec) could not be blocked by atropine. Furthermore the endocrine responses following electrical vagal stimulation sometimes appeared to be mediated via a noncholinergic mechanism, since neither the gastrin [6, 7] , nor the insulin [8] nor glucagon [9] release responses induced by such stimulation could be blocked by atropine.
Peptides in the Vagus
The atropine resistance of the vagally controlled release of gastrointestinal hormones might hypotheticaIly be explained by a release of these peptides 0012-186X/81/0020/0337/$01.20 directly from vagal nerve terminals. Looking for such a "vagal pool" of gastrointestinal hormones, vagal extracts were assayed for various peptides. We were able to demonstrate the presence of gastrin [10] somatostatin [11] and insulin-like immunoreactivity (to be published) in extracts of the subdiaphragmatic vagus. The gastrin-like immunoreactivity corresponds to gastrin-17 and small amounts of gastrin-34 in cats, dogs and humans [10] . Large amounts of met and leu-enkephalin (ratio 4: 1) are present in the vagus as determined by radioreceptorassay in combination with HPLC (Uvngs-Wallensten and Stein, unpublished).
Lundberg et al. [12, 13, 14] have made an extensive study of peptidergic fibres in the vagus using immunohistochemical methods. They have demonstrated the presence of substance P, gastrin-CCK, VIP, enkephalin and somatostatin-like immunoreactivity after ligation of vagal nerves, suggesting that the peptides are transported in the nerves. They have also been able to show VIP, somatostatin, substance P and gastrin-CCK-like immunoreactivity in the cell bodies of the nodose ganglion, indicating that these peptides are present in sensory neurons. Most of the peptides are transported distally in the vagus irrespective of their presence in motor or sensory neurons.
The substance P-like immunoreactivity of the vagal nerve extracts has been further characterized by gel filtration. A peak corresponding to synthetic substance P as well as a larger molecule was found. Dockray et al. [15] have shown that in most vagal extracts from dogs, CCK-8 seems to predominate over gastrin-17 [16] , whereas some dog vagi contain only gastrin-17.
Release of Peptide Following Vagal Stimulation
Most of the peptides demonstrated in the vagus have been shown to be released in response to vagal activation. Gastrin [7, 18] 
Release of Peptides from Peripheral Somatic Nerves
In order to study the release of neurogenic peptides, we shifted our interest to the peripheral somatic nerves. The general occurrence of peptides to all kinds of nervous tissue suggested to us that the sciatic nerve might also contain peptides. To test this hypothesis, an experimental model consisting of an extirpated cat leg was designed. During the experiments the vascular system of the cat leg is perfused with Tyrodes solution at a rate of 1 ml/min at room temperature. The perfusates are collected in icechilled tubes, boiled for 1 rain and then frozen until assayed for peptides.
In response to electrical stimulation of the sciatic nerve, gastrin-like immunoreactivity appeared in the perfusate [26] . In experiments giving high yields, the nature of the gastrin-like immunoreactivity has been characterized as gastrin-17 by Dockray and Gregory (to be published). We have also been able to show a release of insulin [27] and somatostatin-like immunoreactivity (Uvn~is-Wallensten and Efendic, unpublished) in response to electrical stimulation of the sciatic nerve.
A release of these presumably neurogenic peptides can also be induced by adding drugs to the perfusion medium. Sulphonylureas (tolbutamide and glibenclamide) and KC1 are potent releasers of both gastrin [28] and insulin-like material [29] from the sciatic nerve.
Both gastrin-and insulin-like immunoreactivity appear in perfusate from the Langendorff-heart preparation in response to electrical stimulation of the vagosympathetic trunk [26, 271 or following addition of KC1 to the perfusion medium (to be published). Gersl et al. [30] have demonstrated that the concentration of gastrin (chromatographically identified as gastrin-17) is 10 to 100 fold higher in the heart atria than in the ventricles. The atria are richly vagally innervated but the ventricles are not. It therefore seems plausible that the gastrin extracted from the atria, at least to some extent, derives from vagal terminals.
Peptides in Peripheral Somatic Nerves
Lundberg et al. [13, 31] and H6kfelt et al. [32] have by means of immunocytochemistry demonstrated the presence of gastrin-CCK, somatostatin, substance P, enkephalin and VIP-immunoreactive fibres in the sciatic nerve after ligation of the nerve. The peptide pattern is very similar to that of the vagal nerves and the distribution of peptides in sensory or motor fibres also agrees well. Gastrin-CCK, somatostatin, VIP and substance P can also be demonstrated in sensory spinal ganglia suggesting they are located in sensory neurons.
Interestingly insulin-like immunoreactivity has not been demonstrated immunocytochemically. We have recently been able to show that insulin-like material accumulates proximally following ligation of the sciatic nerve (Uvnfis-Wallensten and Uvnfis, to be published). The insulin-like material found in extracts of the vagus, the atria of the heart and in heart perfusates is indistinguishable from pancreatic insulin in several chromatographic systems (Uvn~s and Uvnfis-Wallensten, to be published). We therefore feel confident that the insulin-like material we study corresponds to insulin or a very similar peptide.
Function of Peptides in Neurons
As yet, not much is known about the physiological functions of the peptidergic neurons in the vagi. VIPergic neurons have been suggested to mediate the vagally induced gastric relaxation and also some reflexly induced vasodilator responses in the intestine [33] . The gastrointestinal sphincters are richly innervated by VIPergic [34] and enkephalin-containing fibres [35] . It has recently been proposed that VIP and enkephalin might mediate the vagally-controlled relaxation and contraction of the pylorus respectively [36] .
Substance P is a potent vasodilator and has been suggested to be involved in the axon reflex inducing antidromic vasodilation [37] . Since substance P is released into the antral lumen in response to vagal stimulation [23] it might be assumed to have similar vasodilator actions in the gastrointestinal tract. Bombesin might, as mentioned above, be involved in the vagally-induced release of gastrointestinal (and perhaps pancreatic) hormones. Somatostatin inhibits secretory and motor functions in the gastrointestinal tract [38] . It is possible that selective activation of vagal somatostatin fibres may be one of the ways by which the CNS can control gastrointestinal functions, perhaps via modulation of cholinergic transmission [39] . The occurrence of gastrin in the heart and in peripheral neurons suggests that neurogenic gastrin might be involved in a function common to most parts of the body. It is well known that gastrin exerts atrophic influence on the mucosa of the corpus and intestine [40] . Furthermore, infusions of gastrin to pregnant dogs or puppies have been shown to cause hypertrophy of the pylorus [41] . Analogously, gastrin might have trophic effects on striated muscles as well. Such an effect might explain why the size of a muscle increases in response to increased physical activity. It is also possible that gastrin modulates cholinergic transmission by increasing the release of aetylcholine [421.
The last peptide to be discussed is insulin. To us it seems reasonable to assume that neurogenic insulin regulates metabolic processes in the same way as insulin carried in the blood does. However with a neural supply of insulin, the metabolic effects of insulin could be increased locally in a tissue where it is needed. Thus, insulin might be released in response to activation of the nerves (autonomic or somatic) innervating smooth or striated muscles, together with acetylcholine (and other peptides) to cope with the acute metabolic needs of the working muscle. The occurrence of Gastrin-17 in the heart. Acta Physiol Scand 31. Lundberg JM, H6kfelt T, Nilsson G (1978) 
Discussion after Uvn~is-WaUensten's Presentation
Steffens: I am interested in the physiological function of the insulin you have found in the somatic nerves. Do you feel that the insulin is a neurotransmitter in the limb?
Uvniis-Wallensten: I think that the insulin released when we stimulate the nerves acts the same way as circulating insulin, but only very locally. When motor activity is increased, there is of course a release of acetylcholine which activates the nicotinic receptors. At the same time, there may be a small amount of insulin released to stimulate glucose uptake; and VIP may be released in small amounts to dilate the blood vessels in the immediate area.
There may also be a little gastrin to exert atrophic effect. It would obviously be much more efficient for muscles to have needed peptides available locally for optimal functioning and not have to depend totally upon the pancreas or other tissues.
Porte: Have you looked for insulin in diabetic animals?
Uvniis-Wallensten: No.
Porte: The reason I ask is that there is now evidence that insulin can be internalized by insulin sensitive tissues. Is it possible that the insulin you are measuring is insulin which circulated to the nerves, was internalized, and appears to be released when the muscle is active? It's well known that nerves are insulin sensitive, and Dr. van Houten has evidence that neurons in the brain can internalize insulin. Perhaps the nerves to the limb take up insulin centrally and it is transported along the axons to the muscles. This would mean that the internalized insulin does not go through the lysosomal pathway.
Uvniis-Wallensten:
All of what you say is possible, but it would have to occur for several peptides. Further, the gastrin which we have measured is gastrin-17, which occurs in very low concentrations in the circulation of cats.
Porte: Yes, but gastrin is known to exist in some neurons and their cell bodies. Insulin may be a different story because it is not easy to find immunoreactive insulin inside cell bodies. At least we can't find it.
Uvnds-Wallensten: I agree, because we haven't been able to find it either; but there are other possibilities. There is a precedent for two or more transmitters occurring in the same neuron. Perhaps acetylcholine and insulin co-exist in motor neurons and that the acetylcholine somehow interferes with visualization of the insulin.
Bray: You seem to have just destroyed a long-standing concept I have had that one neuron releases only one transmitter type. Do your data really show that more than one transmitter is found and released from the same neuron, or is it possible in your experiments that you stimulate a number of small axons, each of which has its own, unique transmitter?
Uvniis-Wallensten: My own data cannot differentiate these; but considerable data from H6kfelt's group now show the co-existence of norepinephrine and somatostafin, of VIP and acetylcholine, and of dopamine with gastrin or CCK.
Bray: And are these examples found in the same terminal of one axon?
Uvnds-Wallensten: Yes.
Smith:
It is also possible, as recently suggested by Polak and Buchan (J Histochem Cytochem (1980) 28: 618) that the presence of amines within the cell blocks or masks a portion of the peptide molecule such that antibodies do not react with the peptide. We were recently doing some work with motilin, and we had an antibody which picked up MLI (motilin-like immunoreactivity) in serotonin-containing enterochromaffin cells whereas other motilin antibodies would not. The histological method used may be very important when looking at neurons with more than one transmitter. For example, it has often been observed that the indirect fluorescence technique works well in a given situation where the peroxidase-antiperoxidase technique, which is supposedly one to ten thousand times more sensitive, does not work at all. Some antibodies have been shown to find somatostatin in nerve cell bodies but not in fibers, and others find exactly the opposite. So there are a number of technical problems for which we have no easy answer.
Goldman: Is it possible that the binding of a peptide differs in different parts of a neuron?
Smith: It's very probable.
Fernstrom." I think that it's a reasonable hypothesis that the same nerve terminal might contain more than one transmitter, but you must be cautious. There's a good example of a sympathetic postganglionic nerve to the pineal gland which secretes norepinephrine but which also contains considerable serotonin. The serotonin appears non-functional. The pineal makes so much of it that some leaks out and gets concentrated by these nerve endings. So the neuron has one actual transmitter, norepinephrine, and one false transmitter. So I think that the chemical demonstration of two transmitter candidates should be interpreted cautiously.
Uvniis-Wallenstein:
In the instance of VIP and acetylcholine, I think it has been shown very convincingly by Drs. Lundberg and .,~kngg~rd that both are required as a part of the secretory product in the salivary gland. If you apply only acetylcholine to the gland, or only VIP, huge amounts are required to get a response and the secretion is not normal. When the two are combined, minute amounts are very effective. Likewise, acetylcholine and gastrin more efficiently stimulate gastric acid secretion together than either alone.
Fernstrom: What's the possibility that when you crush a nerve, as in your experiments, growth cones foim and a number of metabolic changes occur in the nerves and Schwann cells such that a super-binding of insulin and perhaps other peptides occurs? If this occurs, the material
